The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...
The second batch of Commissioner's national priority vouchers (CNPVs) has been published by the FDA, and includes new GLP-1 agonists for weight-loss from Eli Lilly and Novo Nordisk and drugs for ...
The current AI regression testing systems consider the new code changes, past failures, and dependency indicators to decide which test cases are the most important to a particular release. Areas with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results